collection
MENU ▼
Read by QxMD icon Read
search

Roflumilast is no miracle

shared collection
1 papers 0 to 25 followers
By Jason Mann No BS pulmonary critical care fellow
https://www.readbyqxmd.com/read/24347460/benefits-and-harms-of-roflumilast-in-moderate-to-severe-copd
#1
Tsung Yu, Kevin Fain, Cynthia M Boyd, Sonal Singh, Carlos O Weiss, Tianjing Li, Ravi Varadhan, Milo A Puhan
BACKGROUND: Roflumilast, a phosphodiesterase 4 inhibitor, has been approved for the prevention of chronic obstructive pulmonary disease (COPD) exacerbations. It is unclear which patients will have a favourable benefit-harm balance with roflumilast. Our aim was to quantitatively assess the benefits and harms of roflumilast (500 µg/day) compared with placebo. METHODS: We used summary data released by the US Food and Drug Administration to estimate the treatment effects of roflumilast...
July 2014: Thorax
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"